mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
4e-14 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-12 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
5e-12 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
5e-12 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
6e-12 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
8e-12 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-11 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-11 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
4e-10 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-09 |